KR960014781B1 - Process for the preparation of toothpaste composition - Google Patents
Process for the preparation of toothpaste composition Download PDFInfo
- Publication number
- KR960014781B1 KR960014781B1 KR1019930001685A KR930001685A KR960014781B1 KR 960014781 B1 KR960014781 B1 KR 960014781B1 KR 1019930001685 A KR1019930001685 A KR 1019930001685A KR 930001685 A KR930001685 A KR 930001685A KR 960014781 B1 KR960014781 B1 KR 960014781B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- toothpaste composition
- sericite
- toothpaste
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 구강내 건강을 증진시킬 수 있는 무기물이 다량 함유된 치약조성물의 제조방법에 관한 것이다.The present invention relates to a method for preparing a toothpaste composition containing a large amount of minerals that can promote oral health.
식전후에 통상의 치솔에 묻혀서 사용하는 각종 연고형태 또는 고상의 치양이 시판되고 있으며 이들은 주성분으로 각종 연마제와 계면활성제외에 향미성분, 피부보호제, 마찰강화제 등을 배합하여 종래의 치약조성물보다 개선된 효과를 얻고자 다양한 치약조성물이 제공되고 있다.Various types of ointment or solid toothpaste, which are buried in ordinary toothbrushes before and after meals, are commercially available.These ingredients include various abrasives and surfactants as well as flavor components, skin protectants, and friction reinforcing agents. To obtain a variety of toothpaste compositions are provided.
본 발명은 각종 무기물 성분을 다량 함유한 광물류 혼합물을 가공처리한 무기조성물을 통상의 치약조성물에 배합한 것이다. 본원발명의 무기물조성물은 한국특허공고90-2937호의 화장비누 제조방법에서 사용하여 그 효과가 입증된 것으로서 이성분을 치약에 함유시켜 구강내 건강을 증진시키는 것에 목적이 있다.In the present invention, an inorganic composition obtained by processing a mineral mixture containing a large amount of various inorganic components is blended with a conventional toothpaste composition. The inorganic composition of the present invention has been proved to be effective in the method of manufacturing a cosmetic soap of Korean Patent Publication No. 90-2937. The purpose of the present invention is to improve the oral health of the toothpaste by containing this component in toothpaste.
즉 본 발명은 연마제, 습윤제, 결합제, 기포제, 감미제, 방부제, 약효제, 향료 등으로 구성되는 공지의 치약 조성물에 있어서, 세리사이트(Sericite : 견운모), 할로이사이트(Halloysite : 적석지), 무스코바이트(Muscovite : 백운모), 악티노라이트(Actinolite : 양기석), 활석을 일정비율로 배합하여 분쇄, 탈철, 고온소성의 제조공정을 거쳐서 생산된 무기조성물(이하"세리온조성물"이라 한다)을 배합하여 구강내 피부보호의 치아의 저항성등을 개선시킨 새로운 치약조성물의 제조방법을 제공하는 것을 목적으로 한다.That is, the present invention is a known toothpaste composition composed of an abrasive, a humectant, a binder, a foaming agent, a sweetener, a preservative, a medicinal agent, a fragrance, etc., Sericite (Hillysite), Haloysite (Halloysite), Musco Combining bitcoin (Muscovite), actinite (Actinolite) and talc in a proportion, the inorganic composition (hereinafter referred to as "cerion composition") produced through the manufacturing process of grinding, iron removal and high temperature baking It is an object of the present invention to provide a method for manufacturing a new toothpaste composition that improves the resistance of teeth in oral skin protection.
이하 본 발명의 치약조성물 제조방법을 공정별로 설명한다.Hereinafter, the method of manufacturing the toothpaste composition of the present invention will be described for each step.
[무기조성물 제조방법][Inorganic composition manufacturing method]
1. 분쇄공정1. Crushing process
세리사이트, 할로이사이트, 무스코바이트, 악티노라이트, 활석 원광을 선별채취 하여 충분히 건조처리한다. 선별채취공정에서 불필요한 이물질이 다량 함유된 것을 기계적인 방법으로 일차선별하는 것이며 이어서 통상의 마찰드럼식이나 회전분마기에 넣고 고속분마처리하여 적어도 280메쉬이상의 수준으로 마쇄한다.Serisite, halosite, muscobite, actinite and talc ore are collected and thoroughly dried. In the sorting process, a large amount of unnecessary foreign matter is first sorted by a mechanical method, and then put into a conventional friction drum type or rotary grinding machine, and ground at a speed of at least 280 mesh by high-speed grinding.
2. 탈철공정2. De-ironing Process
일차로 분쇄된 분말 회전드럼이나 컨베이어 벨트상에서 강한 자력선을 투과시켜 철분이 자력선을 따라 분말증에서 묻혀 나오도록 한다. 또한 전기자석을 분말내에 휘어져 주어 충분히 철분을 흡착제거한다.A strong magnetic force line is transmitted through a powder pulverized drum or a conveyor belt that is primarily crushed so that iron is buried out of the powder along the magnetic line. In addition, the electromagnet is bent in the powder to sufficiently adsorb and remove iron.
3. 선별공정3. Sorting process
1) 건식선별법1) Dry selection method
280 메쉬이상의 분말이 공중에 비산되는 정도의 속도로 공기를 송풍시켜 비산된 것만을 별도의 수집양을 통하여 수집한다.Air is blown at a speed at which the powder of 280 mesh or more is scattered in the air, and only the scattered powder is collected through a separate collection amount.
2) 수비법2) defense
분말을 10~20배의 물에 부유시켜 물 상층부에 부유하는 것만을 수집선별 한다. 이상의 건식법과 수비법을 동시에 채용하여 사용할 수도 있다.The powder is suspended in 10 to 20 times of water and collected only for floating in the upper water layer. The dry method and the defensive method mentioned above can also be employ | adopted and used simultaneously.
4. 배합공정4. Mixing process
세리사이트 15~25중량%, 할로이사이트 30~50중량%, 무스코바이트 20~30중량%, 악티노라이트 5~10중량%, 및 활석 10~20중량%를 취하여 공지의 훈련조로 균질하게 섞는다.Take 15 to 25% by weight of sericite, 30 to 50% by weight of halosite, 20 to 30% by weight of muscobite, 5 to 10% by weight of actinite, and 10 to 20% by weight of talc. .
5. 소성공정5. Firing process
상기 배합공정에서 충분히 훈련된 것을 300~350℃의 밀폐된 환원소성로에 넣고 30분이상 방치한다.Those sufficiently trained in the compounding process are placed in a closed reducing furnace at 300-350 ° C. and left for at least 30 minutes.
[치약제조][Toothpaste Manufacturing]
이상의 소성공정이 완성된 세리온 조성물 분말을 냉각하여 공지의 치약조성물의 중량을 기준으로 하여 20 내지 60중량% 배합한다. 즉, 가능한한 많이 첨가할수록 효과가 좋으나 60중량%보다 많게 배합하면 타성분의 훈련성이 저하되어 점조성이 극히 불량하므로 사용이 어렵게 때문이다. 20중량%보다 적게 배합하면 본래 목적하는 약리효과가 발휘될 수 없기 때문에 20중량%를 최저 배합량으로 하였다.The cerion composition powder having the above firing process is cooled and blended with 20 to 60% by weight based on the weight of the known toothpaste composition. In other words, the more effective as possible, the better the effect, but if blended more than 60% by weight of the other components of the training is lowered because the extremely poor consistency is difficult to use. Since blending less than 20 weight% cannot exhibit the desired pharmacological effect originally, 20 weight% was made into the minimum compounding quantity.
본 발명에서 사용되는 연마제는 인산일수소칼슘, 침강실리카, 실리카겔, 탄산칼슘, 함수알루미나, 불용성 메타인 산나트륨, 피로인산칼슘, 지로코늄리케이트, 수산화인회석 등에서 선택된 1 또는 2이상의 혼합물이 1 내지 90중량% 사용되며, 이것은 치약의 연마력, 적용대상, 효능, 효과에 따라 조절이 가능하며 바람직하게는 1내지 50중량%가 적당 하다. 습윤제는 치약이 공기중에 노출될 때 고화되는 것을 방지하는 것으로서 솔비톨액(70%), 글리세린(TG), 폴리에틸렌글리콜(PEG), 프로필렌글리콜(PG)의 다가알콜중의 1또는 2이상의 혼합물을 10내지 70중량% 사용한다.The abrasive used in the present invention may be a mixture of one or two or more selected from calcium monohydrogen phosphate, precipitated silica, silica gel, calcium carbonate, hydrous alumina, insoluble sodium phosphate, calcium pyrophosphate, zirconium carbonate, hydroxyapatite and the like. 90% by weight is used, which can be adjusted according to the polishing power, application, efficacy and effect of the toothpaste, preferably 1 to 50% by weight is appropriate. The humectant prevents the toothpaste from solidifying when exposed to the air.The humectant is a mixture of one or two or more of polyhydric alcohols of sorbitol solution (70%), glycerin (TG), polyethylene glycol (PEG) and propylene glycol (PG). To 70% by weight.
결합제는 고체와 액체를 결합시켜 고액분리를 방지하는 CMC(카르복시메틸셀룰로스), 카라기난의 칼슘 또는 나트륨형, 수용성 폴리비닐아크릴수지, 폴리비닐피롤리돈, 잔탄검, 마그네슘 알루미뉼실리케이트중의 어느 한가지 또는 둘이상의 혼합물을 0.1 내지 3.0중량% 사용된다.The binder is any one of CMC (carboxymethylcellulose) which combines solid and liquid to prevent solid-liquid separation, calcium or sodium type of carrageenan, water-soluble polyvinylacrylic resin, polyvinylpyrrolidone, xanthan gum and magnesium aluminule silicate. Or 0.1 to 3.0% by weight of two or more mixtures.
기포제는 계면장력의 저하로 세정작용을 보다 활발히 작용시키는 것으로서 알킬황산 나트륨, 라우로일사르코일산나트륨등의 알킬황산나트륨과 같은 음이온계면활성제, 폴리옥시에틸렌폴리옥시프로필렌계 축합고분자물질, 폴리옥시에틸렌 경화피마자유, 폴리옥시에틸렌솔비탄지방산에스테르, 솔레탄지방산에스테르, 수크로스지방산에스테르등의 비이온성 계면활성제중의 어느 한가지 또는 둘 이상의 혼합물 0.1 내지 5중량%를 배합 가능하며 표면장력이 40 내지 50dyne/㎠인 것이 바람직하다.Foaming agent acts more aggressively by lowering the interfacial tension, and is an anionic surfactant such as sodium alkyl sulfate, sodium lauroyl sarcoyl sulfate, polyoxyethylene polyoxypropylene condensation polymer material, polyoxyethylene curing 0.1 to 5% by weight of any one or a mixture of two or more of nonionic surfactants such as castor oil, polyoxyethylene sorbitan fatty acid ester, soletan fatty acid ester and sucrose fatty acid ester can be blended and the surface tension is 40 to 50 dyne / It is preferable that it is cm <2>.
감미제로는 합성 또는 천연의 비발효성당 등이 주로 사용되며 대표적으로는 삭카린나트륨, 아스파탐, 스테비오사이드, 아세토설팜, 감초산 또는 감초산의 암모늄, 칼륨염, 이성화당, 솔비톨 등이 사용될 수 있으며 사용량은 0.01 내지 0.5중량%가 적당하다.As the sweetening agent, synthetic or natural non-fermentable sugars are mainly used. Examples of the sweeteners include sodium saccharin, aspartame, stevioside, acetosulfame, ammonium of licorice or licorice, potassium salt, isomerized sugar, sorbitol, etc. The amount of use is suitably 0.01 to 0.5% by weight.
향료는 페파민트, 스피아민트, 멘톨, 가드본등을 주제로하여 아니스, 살리실산 메틸, 레몬유, 유칼립톤, 계피알데히드등을 첨가하여 사용할 수 있으며 사용량은 0.05 내지 1.5중량%이다.The fragrance can be used by adding anise, methyl salicylate, lemon oil, eucalypton, cinnamon aldehyde, etc., with the theme of peppermint, spearmint, menthol, and guardbone, and the amount is 0.05 to 1.5% by weight.
그 외에 파라옥시안식향산 에스테르, 안식향산, 안식향산나트륨, 살리실산 등의 식품의 약품용 방부제가 0.01내지 0.5중량% 사용 가능하다.In addition, 0.01 to 0.5% by weight of a food preservative for foods such as paraoxybenzoic acid ester, benzoic acid, sodium benzoate and salicylic acid can be used.
이상의 치약조성물에 배합된 세리온조성물중은 옛부터 한방에서 약용으로 사용되는 것으로서 악티노라이트는 유백색, 청백색 내지 청회색 또는 황갈색으로 혼재하여 성기능감퇴회복, 자궁허냉, 월경부조, 허리무릎냉통에 환이나 산제로 복용하며, 할로이사이트는 민성설사, 장출혈, 체증, 위궤양, 십이지장궤양, 구토, 외상에 유효하며, 무스코바이트는 체증, 장염, 설사, 외상출혈, 창독에 유효하다고 소개되어 있다.The cerion composition blended with the above toothpaste composition has been used for medicinal purposes since ancient times. Actinite is mixed with milky white, bluish-white to bluish-grey or yellowish brown color. Taken as a powder, halosite is effective for febrile diarrhea, intestinal bleeding, congestion, gastric ulcer, duodenal ulcer, vomiting, and trauma, and muscobite is effective for congestion, enteritis, diarrhea, traumatic bleeding, and venom.
한편 세리사이트에 함유된 셀레늄은 다음의 약리효과가 보고되어 있다. 고농도 셀레늄이 암억제에 유효하다는 보고를 넬슨등(1943), 클록과 헨드릭(1954), 불가레프와 체르커스(1967). 슈뢰더와 미체너(1971), 가드너(1973), 반 하우웰링(1979)등의 다수 학자가 입증하고 있으며, 리차드 에이. 패스워터박사가 지은 "식품과 의약으로서의 셀레늄"미합중국 커넥티커트, 뉴카나안, 키즈출판사)에서 면역반응자극, 본 발명의 세리온 분말 조성물을 함유하는 치약조성물은 이같은 셀레늄의 약리적 유효 작용외에도 수많은 초 희귀금속들이 다량 함유된 치약 조성물이다.Meanwhile, the following pharmacological effects of selenium contained in sericite have been reported. Nelson et al. (1943), Clock and Hendrick (1954), Bulgave and Chercus (1967) report that high concentrations of selenium are effective for cancer suppression. Schroeder and Michener (1971), Gardner (1973) and Van Howelling (1979) have been proven by Richard A. In addition to the pharmacologically effective action of selenium, the toothpaste composition containing the selenium powder composition of the present invention is produced in Dr. Passwater's "Selenium as a food and medicament" in US Connecticut, New Canaan, and Kids Publishing. Toothpaste composition containing a large amount of ultra rare metals.
일반적으로 인체에 유익한 영양분은 C, H, N, P, O, S와 같은 대량 요구분과 Na, K, Mg, Ca, Cl, PO4, SO4와 같은 마크로미네랄이 있다. 그외에도 Fe, Zn, Ca와 같은 흔적량이 요구되는 것은 물론 극히 미량이 요구되는 F, I, Se, Si, As, B와 같은 비금속물질과 Mn, Mo, Co, V, Ni, Ca, Sn, Pb, Li과 같은 금속물질이 있다.In general, nutrients that are beneficial to the human body include large amounts such as C, H, N, P, O, and S, and macro minerals such as Na, K, Mg, Ca, Cl, PO 4 , and SO 4 . In addition, trace amounts such as Fe, Zn, and Ca are required, as well as non-metallic substances such as F, I, Se, Si, As, and B, and Mn, Mo, Co, V, Ni, Ca, Sn, There are metal materials such as Pb and Li.
인체에 있어 불소와 붕소와 같은 특별한 경우를 제외하고 성인이 경우 이같은 흔적량이 요구되는 성분이 10mg미만이며, 이들 성분에 대한 인체내 화학작용은 아직 실험적으로 규명되지는 못하고 부분적으로 인정되며 경험적, 결과론적 실험데이타로 그 중용성이 인정되는 것이다. 즉, 논문 "필수트레이스 성분에 대한 새로운 전망"(New Perspectives on the essential trace elements)(플로리다 주립대학, Tallahasse, 얼프리드, V01. 62, 11호, 1985. 11)에서 밝히듯이 생물체에 대한 미량요소의 결핍, 적정, 독성등의 단계적 시험결과 일정량보다 적거나 많을때 생체에 극독성도 되는 동시에 극히 유익한 성격을 갖는 것이다.Except for special cases such as fluorine and boron in the human body, the trace amount required for such traces is less than 10 mg in adults, and the chemical reactions in the human body for these components have not yet been experimentally identified, partially acknowledged, empirical, and result. Its significance is recognized as a theoretical experimental data. In other words, trace elements for living organisms, as stated in the paper "New Perspectives on the essential trace elements" (Florida State University, Tallahasse, Ulfried, V01. 62, 11, Nov. 1985). When the result of the stepwise test such as deficiency, titration, and toxicity is less or more than a certain amount, it is extremely toxic to the living body and has an extremely beneficial character.
즉, 망간은 결핍시 성장발육 저해, 골기형, 생체막 기형이 되는 반면 적정한 공급시 탄수화물대사 촉진, SOD돌연변이원 방어등에 관여하는 것이다.In other words, while manganese is deficient in growth growth, bone malformation, biological membrane malformation, while adequate supply promotes carbohydrate metabolism, SOD mutagenicity is involved.
몰리부덴의 경우 부족시 성장저해가 되나 적정시 산화효소에 관여한다. 코발트의 경우에도 부족시 빈혈, 성장지연이 되며 적정시 비타민 B12의 구성요소로 되는 것이다. 크롬도 부족시 인슐린 분비가 방해되나 적정시 인슐린 활성화에 기여한다. 바듐도 부족시 성장저해가 되며, 적정시 Na신경전달 펌프조절, APT분해 효소등의 저해에 작용한다.In the case of molybdenum, growth is inhibited when it is insufficient, but is involved in oxidase when titrated. In the case of cobalt, anemia and growth retardation is insufficient, and it becomes a component of vitamin B 12 when titrated. Insufficient chromium also interferes with insulin secretion but contributes to insulin activation when titrated. Lack of barium also leads to growth inhibition, and when appropriate, it acts on the inhibition of Na-neurotransmission pump regulation and APT degrading enzymes.
니캘은 부족시 성장지연, N이용률, Fe대사 감소가 되며, 적정시 요소분해효소 구성분이 되고 혈구분해가 감소된다.Nickel reduces growth retardation, N utilization, and Fe metabolism when lacking, and becomes urease component when titrated, and hemolysis is reduced.
카드늄은 부족시 성장지연, 재생감소가 되고 적정시 리보솜의 신장요소를 자극한다.Cadmium delays growth and decreases regeneration when insufficient, and stimulates elongation of ribosomes when titrated.
주석은 부족시 성장지연이 되고 적정시 플라빈과 협동작용한다. 납은 부족시 성장지연과 재생감소가 되며 적정시 Na펌프에 작용한다.Tin is delayed by growth and runs with flavin when titrated. Lead causes growth retardation and regeneration reduction when insufficient, and acts on Na pump when titrated.
실리콘은 부족시 성장억제, 골과 기실 기형이 되며, 적정시 결합조직과 골세포에 구조적 역할을 한다. 비소는 부족시 성장, 재생, 심박역할에 문제가 생기며 적정시 아르기닌의 분해증가와 메틸화합물의 대사에 관여한다. 붕소는 부족시 질소고정의 저해와 앵글로스펌의 성장이 되며, 적정시 막기능, 핵산생합성, 리그닌 합성에 관여한다.Silicon is inhibited by growth, lack of bone and vesicle malformation, and plays a structural role in connective tissue and bone cells when appropriate. Arsenic causes problems with growth, regeneration, and heart rate when deficient, and is involved in the increase of arginine degradation and metabolism of methyl compounds when titrated. Boron is inhibited by nitrogen fixation and growth of anglos perm when insufficient, and is involved in membrane function, nucleic acid biosynthesis and lignin synthesis when titrated.
이상의 설명과 같이 인체를 유지, 재생함에 필수적인 각종 금속 또는 비금속물질이 대량 포함된 본 발명의 치약 조성물은 장시간 사용시 인체의 자연적인 회복력과 재생을 도와 각종 유효한 효과를 얻을 수 있다.As described above, the toothpaste composition of the present invention containing a large amount of various metals or non-metallic materials essential for maintaining and regenerating the human body may help various resilience and regeneration of the human body for a long time to obtain various effective effects.
즉, 오염이 심한 대도시근교등에서 재배되거나 농약, 합성비료가 다량 사용된 토양은 산성화되면서 Ti, Mn, Co, Fe, Aℓ, Mg, Ca, Se 등이 탈리되어 정상토양보다 필요한 무기물 함량이 1/100~1/1000 이하로 되기에 이같은 별도의 무기물공급은 현대에 이르러 필수적이 되었으며 본발명의 치약조성물 제조방법도 이같은 무기물공급에 기초하여 완성된 것으로서 이들 성분이 치아표면, 구강표면등에 치솔질중에 작용하여 상기한 약리효과를 발휘하는 것이다. 그 결과 풍취, 충치, 구취, 구강암 예방과 치료효과를 보이는 것이다.In other words, soils grown in heavily polluted metropolitan areas, or where pesticides or synthetic fertilizers are used, are acidified, and Ti, Mn, Co, Fe, Aℓ, Mg, Ca, Se, etc. are desorbed. As it is below 100 ~ 1/1000, such separate mineral supply has become essential in modern times, and the manufacturing method of toothpaste composition of the present invention is also completed based on such mineral supply, and these ingredients act on the tooth surface, oral surface, etc. during brushing. To exhibit the above pharmacological effect. As a result, it is effective in preventing and treating odor, tooth decay, bad breath, and oral cancer.
즉, 무기물이 세포내 침투시 과산화물에 대한 보호효과, 세포호흡의 유지, 간보호, 돌연변이 유인물이나 암유인물에 대한 무독화촉진, 심근의 강화, 혈관내 섬유소감소 또는 산소 발생이라는 독특한 기능으로 상기한 약리효과를 갖는다고 규명하고 있다. 가장 구체적으로는 클라우스 슈바르쯔박사(Klaus Schwarz,M.D. 1914~1978)는 셀레늄의 노화방지, 면역기능강화가 셀레늄의 막보호에 기인한다고 증명하였고, 더나아가서 세포의 미토콘드리아기능을 개선하며, 프로스타글란딘호르몬 유사물질 생산에도 직접관여하며, 카드뮴 중금속 배설촉진 효과도 증명하고 있다.In other words, the minerals have been described as having a protective effect on peroxides during intracellular penetration, maintenance of cell respiration, hepatoprotection, promotion of detoxification of mutant attractants or cancer attractants, strengthening of myocardium, reduction of intravascular fibrosis or oxygen production. It has been identified as having a pharmacological effect. Most specifically, Dr. Klaus Schwarz (MD 1914-1978) demonstrated that selenium's anti-aging and immune-enhancing effects were attributed to selenium membrane protection, further improving the mitochondrial function of cells and prostaglandin hormones. It is directly involved in the production of analogues and has also demonstrated the effect of promoting excretion of cadmium heavy metals.
[실시예]EXAMPLE
본 발명의 제품을 실제 사용한 결과 다소간의 플라세보적인 효과도 예상되나 잇몸출현 현상이 적어도 3배이상 감소하는 것은 무기물의 잇몸표피내의 침투로 세포의 건강회복과 동시에 미세한 무기질이 과도한 마찰을 막아주어 치솔선단의 직접 마찰을 억제한 것도 예상된다.As a result of the actual use of the product of the present invention, the placebo effect is expected to be somewhat reduced, but the appearance of gums is reduced by at least three times. The infiltration into the gum epidermis of the mineral prevents excessive friction of the cells and at the same time, the fine mineral prevents excessive friction. It is also expected to suppress the direct friction of.
또한 발명의 세리온무기조성물 함량이 증가할수록 표피출현의 방지 효과는 탁월하였으며, 특히 구취예방, 풍치환자의 통증간소, 구내염환자의 치료 기간 단축이 비교예보다 현저하였다.In addition, as the content of the cerion inorganic composition of the invention was increased, the prevention effect of epidermal appearance was excellent. Especially, the prevention of bad breath, the pain simplicity of the landscape patients, and the shortening of the treatment period of the stomatitis patients were more significant than the comparative examples.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930001685A KR960014781B1 (en) | 1993-02-08 | 1993-02-08 | Process for the preparation of toothpaste composition |
FR9307604A FR2701208B3 (en) | 1993-02-08 | 1993-06-23 | Composition of toothpaste. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930001685A KR960014781B1 (en) | 1993-02-08 | 1993-02-08 | Process for the preparation of toothpaste composition |
Publications (1)
Publication Number | Publication Date |
---|---|
KR960014781B1 true KR960014781B1 (en) | 1996-10-19 |
Family
ID=19350534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930001685A KR960014781B1 (en) | 1993-02-08 | 1993-02-08 | Process for the preparation of toothpaste composition |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR960014781B1 (en) |
FR (1) | FR2701208B3 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108514540A (en) * | 2018-04-25 | 2018-09-11 | 陕西理工大学 | A kind of galapectite Chinese traditional medicine tooth powder |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040052736A1 (en) * | 2002-09-12 | 2004-03-18 | The Procter & Gamble Company | Dentifrice compositions comprising talc |
-
1993
- 1993-02-08 KR KR1019930001685A patent/KR960014781B1/en not_active IP Right Cessation
- 1993-06-23 FR FR9307604A patent/FR2701208B3/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108514540A (en) * | 2018-04-25 | 2018-09-11 | 陕西理工大学 | A kind of galapectite Chinese traditional medicine tooth powder |
Also Published As
Publication number | Publication date |
---|---|
FR2701208A3 (en) | 1994-08-12 |
FR2701208B3 (en) | 1995-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101258976B1 (en) | Biologically active nanoparticles of a carbonate-substituted hydroxyapatite, process for their preparation and compositions incorporating the same | |
US4812306A (en) | Toothpaste or dental cream composition and method of preparing same | |
JP2006182790A (en) | Antiplaque oral composition | |
JPH085774B2 (en) | Composition for improving oral hygiene containing bamboo salt | |
KR101337454B1 (en) | Composition of brine thermal water containing skin moisturizing and calming effect, and method for manufacturing the same | |
US4559223A (en) | Silver sulfadiazine and/or zinc sulfadiazine-containing toothpaste or oral medicament | |
KR960014781B1 (en) | Process for the preparation of toothpaste composition | |
KR100204835B1 (en) | Preparation method of pack composition for massage containing yellow soil powder and extracts of pineneedles | |
CN102335111B (en) | Powder toothpaste combination comprising Ag particles and manufacturing method thereof | |
KR100941670B1 (en) | Oral care Composition using Botanical Abrasive | |
JP3131385B2 (en) | Composition containing easily absorbable calcium and method for producing the same | |
RU2426690C2 (en) | Biologically active nanoparticles of carbonate-substituted hydroxyapatite, method of their production and compositions that include them | |
KR101122760B1 (en) | Toothpsate composites using mineral and manufacturing method thereof | |
SU1754104A1 (en) | Tooth powder | |
JP2020138958A (en) | Method for producing beauty and health composition containing water-soluble silicon and method for producing water-soluble ionized silicon | |
KR100646706B1 (en) | Composition of facial powder pack using alginate and two positive ion (ii) materials | |
KR102246651B1 (en) | Cosmetic composition for removing fine dust or heavy metal | |
EP0663207B1 (en) | Process for preparation of bamboo-salt, bamboo-salt | |
CN102335110B (en) | Powder toothpaste combination comprising Au particles and manufacturing method thereof | |
KR960010967B1 (en) | Process for making inorganic salts | |
WO2012004782A2 (en) | Oral remedial mineral replenishment (omr) preparation | |
EP0267994B1 (en) | The use of a metal complex for the manufacture of a composition for treating dental structures | |
JPH08217631A (en) | Powdery pack cosmetic | |
CA1290252C (en) | Method and compositions for treating dental structures | |
CN112999100B (en) | Anti-allergy polishing paste containing calcium potassium phosphosilicate bioglass |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL Free format text: TRIAL NUMBER: 1996201001337; APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
G160 | Decision to publish patent application | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20061019 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |